Free EMR Newsletter Want to receive the latest news on EMR, Meaningful Use, ARRA and Healthcare IT sent straight to your email? Join thousands of healthcare pros who subscribe to EMR and EHR for FREE!

NFL Uses eCW To Do Concussion Assessment

Posted on July 29, 2013 I Written By

Anne Zieger is veteran healthcare consultant and analyst with 20 years of industry experience. Zieger formerly served as editor-in-chief of FierceHealthcare.com and her commentaries have appeared in dozens of international business publications, including Forbes, Business Week and Information Week. She has also contributed content to hundreds of healthcare and health IT organizations, including several Fortune 500 companies. Contact her at @ziegerhealth on Twitter or visit her site at Zieger Healthcare.

Late last year, the NFL announced that it was using eClinicalWorks’ EMR to standardize their healthcare documentation for players. (Around the same time, the NBA announced that it was implementing Cerner’s EMR.)

Now, we learn that the NFL is gearing up to launch eCW as part of a pilot study of data sharing. It’s also rolling out a program bringing concussion assessment to the field-side.

According to USA Today, the league is distributing iPads to every medical staff member — equipped with X-rays, imaging studies, notes and more — to boost its ongoing efforts to improve assessment of concussions.

All of the iPads rolled out to NFL clinicians will be loaded with X2 software which includes a standard concussion assessment instrument, the Sideline Concussion Assessment Tool (SCAT-3). SCAT-3 is the most advanced version available of neurocognitive test used to determine whether a player has a concussion, USA Today reports.

For most teams, the data collected on the deployed iPads will end up being printed and placed in a paper chart.

However, eight teams — the Steelers, Baltimore Ravens, Denver Broncos, Houston Texans, New England Patriots, New York Giants, New York Jets and San Francisco 49ers — are part of a pilot program in which the results collected on the iPad will be sent via Internet into the patient’s EMR.  Eventually, if the pilot works as expected, the EMR data will be shifted as needed between all 32 NFL teams.

What makes the new pilot a bit unusual is that there’s apparently some politics involved in sharing medical data across the league.

The players, agents and the NFL Players Association are apparently concerned that when team members are being scouted by other teams in the league,  the medical data could potentially be used against them. They’re also concerned as to whether certain health information could work against players in free agency or grievance hearings.

The NFL told USA Today that it’s still working out how it will handle free agent medical records, calling the pilot program a “work in progress.”  The league does not intend to use the EMR to share records between teams until the pilot is over.

EMR Vendors Want Meaningful Use Stage 3 Delay

Posted on January 29, 2013 I Written By

Anne Zieger is veteran healthcare consultant and analyst with 20 years of industry experience. Zieger formerly served as editor-in-chief of FierceHealthcare.com and her commentaries have appeared in dozens of international business publications, including Forbes, Business Week and Information Week. She has also contributed content to hundreds of healthcare and health IT organizations, including several Fortune 500 companies. Contact her at @ziegerhealth on Twitter or visit her site at Zieger Healthcare.

A group of EMR vendors have joined the chorus of industry organizations asking that Meaningful Use Stage 3 deadlines be moved up to a later date.  The vendors also want to see the nature of Stage 3 requirements changed to put a greater emphasis on interoperabilityInformation Week reports.

The group, the HIMSS EHR Association (EHRA), represents 40 vendors pulled together by HIMSS.  Members include both enterprise and physician-oriented vendors, including athenahealth, Cerner, Epic, eClinicalWorks, Emdeon, Meditech, McKesson, Siemens GE Healthcare IT and Practice Fusion.

In comments submitted to HHS, the vendors argue that MU Stage 3 requirements should not kick in until three years after a provider reaches Stage 2, and start no earlier than 2017. But their larger request, and more significant one, is that they’d like to see Meaningful Use Stage 3’s focus changed:

“The EHRA strongly recommends that Stage 3 focus primarily on encouraging and assisting providers to take advantage of the substantial capabilities established in Stage 1 and especially Stage 2, rather than adding new meaningful use requirements and product certification criteria. In particular, we believe that any meaningful use and functionality changes should focus primarily on interoperability and building on accelerated momentum and more extensive use of Stage 2 capabilities and clinical quality measurement.”

So, we’ve finally got vendors like walled-garden-player Epic finding a reason to fight for interoperability. It took being clubbed by the development requirements of Stage 3, which seems to have EHRA members worried, but it happened nonetheless.

While there’s obviously self-interest in vendors asking not to strain their resources on new development, they still have a point which deserves considering.  Does it really make sense to push the development curve as far as Stage 3 requires before providers have gotten the chance to leverage what they’ve got?  Maybe not.

Now, the question is whether the vendors will put their code where their mouth is. Will the highly proprietary approach taken by Epic and some of its peers become passe?